APA (7th ed.) Citation

S, V., S, Z., N, A., K, A., B, C., A, D., . . . AM, C. Y. (2026). Author Correction to "Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%) [Canadian Journal of Cardiology, Volume 41, Issue 10, Pages 1857-1874. DOI: 10.1016/j.cjca.2025.07.027]". The Canadian journal of cardiology. https://doi.org/10.1016/j.cjca.2026.03.026

Chicago Style (17th ed.) Citation

S, Virani, et al. "Author Correction to "Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%) [Canadian Journal of Cardiology, Volume 41, Issue 10, Pages 1857-1874. DOI: 10.1016/j.cjca.2025.07.027]"." The Canadian Journal of Cardiology 2026. https://doi.org/10.1016/j.cjca.2026.03.026.

MLA (9th ed.) Citation

S, Virani, et al. "Author Correction to "Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%) [Canadian Journal of Cardiology, Volume 41, Issue 10, Pages 1857-1874. DOI: 10.1016/j.cjca.2025.07.027]"." The Canadian Journal of Cardiology, 2026, https://doi.org/10.1016/j.cjca.2026.03.026.